3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
21
Observational
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Neoplasms
271
Breast Neoplasms
264
Lung Neoplasms
130
Prostatic Neoplasms
114
Colorectal Neoplasms
108
Carcinoma, Non-Small-Cell Lung
103
Pancreatic Neoplasms
67
Carcinoma, Hepatocellular
53
Ovarian Neoplasms
51
Stomach Neoplasms
49
Multiple Myeloma
49
Hematologic Neoplasms
49
Urinary Bladder Neoplasms
47
Brain Neoplasms
45
Melanoma
42
Leukemia, Myeloid, Acute
42
Head and Neck Neoplasms
40
Esophageal Neoplasms
40
Colonic Neoplasms
38
Disease
37
Liver Neoplasms
36
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Rectal Neoplasms
34
Lymphoma
32
Neoplasm Metastasis
31
Leukemia, Lymphocytic, Chronic, B-Cell
30
Endometrial Neoplasms
30
Recurrence
28
Kidney Neoplasms
28
Uterine Cervical Neoplasms
27
Interventions
Pluvicto
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Castration-resistant Prostate Cancer
×
90 days
×
Clear all
NCT06031805
2026-06-02
PROWESs
AstraZeneca
Recruiting
300 enrolled
NCT06514521
2026-06-01
Post Marketing Study on Pluvicto in Korea
Novartis
Recruiting
278 enrolled
NCT06242509
2026-04-27
AkkPRO
Assistance Publique - Hôpitaux de Paris
Recruiting
52 enrolled